Why selling GLP-1s without clinical infrastructure is not obesity care UK-headquartered digital healthcare company, Voy expanded into India, its fourth international market (alongside the UK, Germany,…
EASO’s new algorithm recommends semaglutide for obesity management The European Association for the Study of Obesity (EASO) has released a new management algorithm, reinforcing the scientific…
